Blood Based Biomarker Market, By Type, By Disease, By Application, By Geography

Description

Blood Based Biomarker Market is estimated to be valued at USD 8.5 Bn in 2026 and is expected to reach USD 16.5 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.5 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	7.00%	2033 Value Projection:	USD 16.5 Bn

The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a cell or organism at a given moment. Blood-based biomarkers can be effective in formulating new diagnostic and treatment proposals. Blood-based biomarkers have significant advantages of being time and cost-efficient

Market Dynamics

Key players operating in the global blood based biomarker market are focusing on adoption of growth strategies such as product launch, collaboration, and fund raise which are expected to drive the market growth during the forecast period. For instance, in September 2020, ONCOtracker, Inc., a West Hollywood-based oncology company and The Binding Site Group Ltd, provides specialist diagnostic products to clinicians and laboratory professionals worldwide, announced they have entered into an exclusive global license and collaboration agreement to develop a novel clinical laboratory test for measuring sBCMA, a novel blood-based biomarker, which has shown promise to monitor and predict outcomes for patients with common blood-based cancers including multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) and other related conditions. Moreover, for instance, in April 2021, Sera Prognostics, a Women's health company had secured US$100 m in Series E financing to advance the commercialization of its PreTRM test for premature birth risk. The PreTRM test is a clinically validated and commercially available blood-based biomarker test, which offers an early, precise, and individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.

Key features of the study

This report provides an in-depth analysis of the Global Blood Based Biomarker Market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global blood based biomarker market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Diadem srl., Proteomedix, Cleveland Diagnostics, F. Hoffmann-La Roche Ltd, GENFIT, Nutech Cancer Biomarkers India Pvt Ltd, SysmOex Corporation, Minomic, Creative Diagnostics, Eisai Co., Ltd., and C2N Diagnostics
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global blood based biomarker market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood based biomarker market

Market Segmentation

By Type
- Screening Biomarker
- Diagnosis Biomarker
- Others
By Disease
- Cancer
- Neurological Disorders
- Others
By Application
- Diagnostics
- Drug Discovery
- Personalized Medicine
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Diadem srl.
- Proteomedix
- Cleveland Diagnostics
- Hoffmann-La Roche Ltd
- GENFIT
- Nutech Cancer Biomarkers India Pvt Ltd
- SysmOex Corporation
- Minomic, Creative Diagnostics, Eisai Co., Ltd.
- C2N Diagnostics

Product Code: CMI4945

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Disease
- Market Snapshot, By Application
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Product Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Blood Based Biomarkers Market, By Type, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Screening Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Diagnosis Biomarker
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

5. Blood Based Biomarkers Market, By Disease, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

6. Blood Based Biomarkers Market, By Application, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Drug Discovery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)
Personalized Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (USD Bn)

7. Blood Based Biomarkers Market, By Region, 2026 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- Diadem srl.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Proteomedix
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Cleveland Diagnostics
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- F. Hoffmann-La Roche Ltd
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- GENFIT
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Nutech Cancer Biomarkers India Pvt Ltd
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- SysmOex Corporation
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Minomic
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Creative Diagnostics
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- Eisai Co., Ltd.
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
- C2N Diagnostics
Company Highlights
Product Portfolio
Financial Performance
Recent Highlights
Market Strategies
Analyst Views

9. Section

References
Research Methodology
About Us